Holen Sie sich die Stockscreener-App
0.00
100.00%
-42.98
Handel nachbörslich:
42.99
42.99
+
Schlusskurs vom Vortag:
$42.98
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$614.51M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
0.00
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$43.00
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
0.00 | 614.51M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-14 | Herabstufung | Barrington Research | Mkt Perform → Underperform |
| 2025-03-07 | Hochstufung | Lake Street | Hold → Buy |
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
Aug Sectors: Can Surmodics Inc expand its profit marginsWeekly Trend Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Aug Closing: What is the cash position of Surmodics Inc2025 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
SRDX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Will Surmodics Inc. stock benefit from upcoming earnings reportsQuarterly Portfolio Report & Advanced Technical Analysis Signals - mfd.ru
Surmodics Buyout: Why This Quiet Medtech Deal Still Matters for US Investors - AD HOC NEWS
What hedge funds are buying Surmodics Inc.Rate Hike & Risk Managed Investment Signals - mfd.ru
Earnings Miss: What is the cash position of Surmodics Inc2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
Macro Review: Is Surmodics Inc likely to announce a buybackJuly 2025 Review & Daily Stock Momentum Reports - baoquankhu1.vn
Aug Setups: Is Surmodics Inc stock a value trapJuly 2025 Movers & Weekly Momentum Stock Picks - baoquankhu1.vn
Buybacks Report: Can Surmodics Inc expand into new markets2025 Price Targets & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Technical Analysis: Will Surmodics Inc be affected by tariffsJuly 2025 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Market Pulse: Is SIM Acquisition Corp I Equity Warrant benefiting from interest rate changes2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Merger Talk: Is IVVD in a consolidation phase2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
SurModics Completes Merger, Ends Credit Agreement - MSN
Will Surmodics Inc. stock deliver shareholder valueJuly 2025 Movers & Growth Focused Stock Reports - Улправда
How risky is Surmodics Inc. stock nowDaily Trainer Picks & updated model highlights and notes - ulpravda.ru
Will Surmodics Inc. stock keep outperforming rivals2025 Market Overview & Precise Entry and Exit Recommendations - Улправда
Why Surmodics Inc. stock attracts high net worth investorsEarnings Beat & Community Trade Idea Sharing Platform - Улправда
MSN Money - MSN
Will Surmodics Inc. stock see insider buying2025 Biggest Moves & Long-Term Safe Investment Ideas - Улправда
Surmodics, Inc.Common Stock (NQ: SRDX - FinancialContent
Pasadena Star-News: Local News, Sports, Things to DoSurmodics, Inc.Common Stock (Nasdaq:SRDX) Stock Quote - FinancialContent
Surmodics falls on report about FTC review of GTCR deal - MSN
Market Review: How Surmodics Inc stock benefits from strong dollarMarket Movers & Reliable Breakout Forecasts - moha.gov.vn
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance - ADVFN
Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance - ADVFN
Surmodics, Inc. (SRDX) Stock Report: Navigating Challenges with Innovative Medical Solutions - DirectorsTalk Interviews
Surmodics (SRDX): Quiet ticker, loud implications – what the latest price action really says - AD HOC NEWS
How Surmodics Inc stock benefits from strong dollarJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Behavioral Patterns of SRDX and Institutional Flows - Stock Traders Daily
Surmodics, Inc. (SRDX) Stock Analysis: Examining Challenges Amid Healthcare Sector Volatility - DirectorsTalk Interviews
Surmodics Unveils New Division to Preserve Biocoat’s Coating Legacy - MyChesCo
Medtech Integer Could Be More Valuable As A Private CompanyActivist Investor Urges Strategic Review - Sahm
Total debt per share of SurModics, Inc. – LS:914178 - TradingView — Track All Markets
Biocoat Announces Formation of Surmodics Services & Technologies Division Following Merger and Divestiture Transactions - BioSpace
SurModics, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Surmodics, Inc. acquired certain assets from Biocoat, Incorporated. - MarketScreener
Tranche Update on Surmodics, Inc.'s Equity Buyback Plan announced on November 6, 2014. - marketscreener.com
Cash per share of SurModics, Inc. – LSX:914178 - TradingView — Track All Markets
How interest rate cuts could boost Surmodics Inc. stockJuly 2025 Levels & Precise Buy Zone Identification - Newser
SurModics: Dividend historical data and projections - marketscreener.com
How sustainable is Surmodics Inc. stock dividend payoutTreasury Yields & Stepwise Trade Signal Guides - Newser
Understanding Momentum Shifts in (SRDX) - Stock Traders Daily
GTCR/Surmodics Win On Divestiture, Share Analysis And Captive Capacity - MarketScreener
Judge Clears PE Firm’s $627M Acquisition of Medical Device Firm, a Setback for the FTC - JD Supra
[EFFECT] SURMODICS INC SEC Filing - Stock Titan
Is Surmodics Inc. stock a safe investment in uncertain marketsWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Will Surmodics Inc. stock recover faster than marketWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Surmodics Inc. stock positioned well for digital economy2025 Big Picture & Safe Entry Zone Identification - newser.com
Private equity firm finally closes $627 million deal to acquire Surmodics - Star Tribune
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.21%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):